Read + Share
Amedeo Smart
Independent Medical Education
Presotto EM, Rastrelli G, Desideri I, Scotti V, et al. Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study. J Endocrinol Invest 2020;43:337-345.PMID: 31542865
Email
LinkedIn
Facebook
Twitter
Privacy Policy